[Angiogenesis inhibitor (TNP-470: AGM-1470)].
Taniguchi
H
H
Kyoto Prefectural Yosanoumi Hospital.
D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D000818:Animals; D016190:Carboplatin / Q000008:administration & dosage; D006528:Carcinoma, Hepatocellular / Q000098:blood supply / Q000188:drug therapy* / Q000556:secondary; D017024:Chemotherapy, Adjuvant; D003510:Cyclohexanes; D004195:Disease Models, Animal; D004359:Drug Therapy, Combination; D006801:Humans; D008113:Liver Neoplasms / Q000098:blood supply / Q000188:drug therapy* / Q000556:secondary; D000077609:O-(Chloroacetylcarbamoyl)fumagillol; D012717:Sesquiterpenes / Q000008:administration & dosage*
D020533:Angiogenesis Inhibitors; D003510:Cyclohexanes; D012717:Sesquiterpenes; D016190:Carboplatin; D000077609:O-(Chloroacetylcarbamoyl)fumagillol